戻る
Repligen Corp (RGEN)価格
RGEN 株価推移チャート
RGEN 財務
Repligen Corp
$162.02
0.2%
$0.33
終値： Jan 16, 16:00:00 GMT-5
$158.86
-1.95%
$-3.15
プレマーケット： Jan 20, 08:18:47 GMT-5
主要データ
前終値
$161.69
始値
$162.29
当日レンジ
$158.86 - $165.15
52週レンジ
$102.96 - $182.52
取引高
625.0K
平均取引高
840.8K
1株当たり利益(TTM)
0.03
配当利回り
--
時価総額
$8.9B
RGENとは何ですか？
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 1,778 full-time employees. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.